<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04124757</url>
  </required_header>
  <id_info>
    <org_study_id>P19.065</org_study_id>
    <nct_id>NCT04124757</nct_id>
  </id_info>
  <brief_title>Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety</brief_title>
  <acronym>EURORELAX</acronym>
  <official_title>The Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety During Laparoscopic Surgery: a Multicenter Strategy Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Leiden University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Leiden University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Muscle relaxants are routinely applied during anesthesia to facilitate endotracheal
      intubation and to improve surgical working conditions. Several investigations have shown that
      a deep neuromuscular block (NMB) improves the surgical working conditions over a moderate NMB
      and effectively precludes sudden deterioration of the surgical field. However, whether the
      improvement of surgical working conditions translates into less intra- and postoperative
      complications remains uncertain. Small prospective or retrospective studies shown an decrease
      of the incidence of intraoperative adverse events and postoperative complications after a
      deep NMB. There is a need to confirm these outcome data prospectively, in a large number of
      patients and clinics and during a variety of surgical procedures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Muscle relaxants are routinely applied during anesthesia to facilitate endotracheal
      intubation and to improve surgical working conditions. Several investigations have shown that
      a deep neuromuscular block (NMB) (post tetanic count (PTC) 1-2 twitches) improves the
      surgical working conditions over a moderate NMB (TOF count 1-3 twitches) and effectively
      precludes sudden deterioration of the surgical field. However, whether the improvement of
      surgical working conditions translates into less intra- and postoperative complications
      remains uncertain. A recent retrospective analysis of neuromuscular management during
      laparoscopic retroperitoneal surgery showed a reduced rate of unplanned 30 day readmissions
      when a deep NMB over a moderate NMB was applied (3.8% vs. 12.7%).In addition, a pooled
      analysis of 4 randomized controlled trials comparing different levels of intra-abdominal
      pressure and neuromuscular blockade during laparoscopic donor nephrectomy, showed a
      significant reduction in the incidence of intra-operative surgical complications from 12.6%
      with moderate NMB to 4.8% with deep NMB.

      These previous observations were made in small prospective or retrospective studies. There is
      a need to confirm these outcome data prospectively, in a larger prospective trial for a
      variety of surgical procedures. We therefore propose a multi-center, randomized controlled
      trial, to study the effect of a deep NMB (PTC 1-2 twitches) versus standard NMB (single
      induction dose rocuronium) in a variety of laparoscopic surgical procedures on the incidence
      of intraoperative adverse events and postoperative outcome data.

      In this study the effect of deep neuromuscular block compared to standard neuromuscular block
      on intra-operative adverse events during laparoscopic surgery using the CLASSIC score system
      is evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 11, 2020</start_date>
  <completion_date type="Anticipated">March 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Classic score</measure>
    <time_frame>Day of surgery</time_frame>
    <description>To study the effect of deep neuromuscular block compared to standard neuromuscular block on intra-operative adverse events during laparoscopic surgery using the CLASSIC score system. (The Classic score; classification of intraoperative complications, is a 6 point scale ranging from no complications (0) to fatal complications (5).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>L-SRS (Leiden Surgical Rating Scale)</measure>
    <time_frame>Day of surgery</time_frame>
    <description>To study the effect of deep neuromuscular block compared to standard neuromuscular block on peroperative surgical working conditions following the Leiden Surgical Rating scale (a 5 point scale, ranging from poor (1) to excellent (5) surgical conditions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 day post-operative complications</measure>
    <time_frame>30 postoperative days</time_frame>
    <description>To study the effect of deep neuromuscular block compared to standard neuromuscular block on 30 day post-operative complications according the Clavien-Dindo score en Comprehensive Complication Index and unplanned readmissions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of recovery (QoR)</measure>
    <time_frame>2 postoperative days</time_frame>
    <description>To study the effect of deep neuromuscular block compared to standard neuromuscular block on Quality of Recovery at post-operative day 1, 2 according to the Quality of Recovery-40</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life (QoL)</measure>
    <time_frame>30 postoperative days</time_frame>
    <description>To study the effect of deep neuromuscular block compared to standard neuromuscular block on Quality of life at post-operative day 30 Short Form-36</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">922</enrollment>
  <condition>Neuromuscular Blockade</condition>
  <condition>Rocuronium</condition>
  <condition>Anesthetics</condition>
  <condition>Anesthesia Complication</condition>
  <condition>Neuromuscular Blocking Agents</condition>
  <condition>Surgery--Complications</condition>
  <arm_group>
    <arm_group_label>Standard neuromuscular blockade</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects will receive regular rocuronium induction dose, followed by bolus foses of 10 mg in case of insufficient conditions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Deep neuromuscular block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive high dose rocuronium induction dose followed by continuous rocuronium administration, to achieve a depth of neuromuscular block of 1-2 twitches post tetanic count</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Deep neuromuscular block</intervention_name>
    <description>Deep neuromuscular block will be achieved with high dose rocuronium to achieve a depth of 1-2 twitches post tetanic count</description>
    <arm_group_label>Deep neuromuscular block</arm_group_label>
    <other_name>High dose rocuronium</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for elective laparoscopic procedure with a complexity according to
             the BUPA classification for case complexity: 'MAJOR', 'MAJOR Plus or 'COMPLEX MAJOR'

          -  ASA (merican society of anesthesiologists) class I-III

          -  &gt; 18 years of age

          -  Ability to give oral and written informed consent

        Exclusion Criteria:

          -  Low or intermediate complexity laparoscopic procedures (BUPA 'SIMPLE' or 'INTER')

          -  Known or suspected neuromuscular disorders impairing neuromuscular function

          -  Allergies to muscle relaxants, anesthetics or narcotics mentioned in paragraph 5.2

          -  A (family) history of malignant hyperthermia

          -  Women who are or may be pregnant or are currently breast feeding

          -  Chronic use of any type of opioid or psychotropic drug

          -  Use of NSAID's shorter than 5 days before surgery

          -  Indication for rapid sequence induction

          -  Contra-indication for sugammadex use (e.g. known sugammadex allergy or Glomerular
             Filtration Rate &lt;30 ml/min)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Monique van Velzen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>LUMC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gijsbert HM Honing, MSc</last_name>
    <phone>0031 71 526 2301</phone>
    <email>g.h.m.honing@lumc.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chris Martini, PhD</last_name>
    <phone>0031 71 526 2301</phone>
    <email>C.H.Martini@lumc.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Université De Lorraine</name>
      <address>
        <city>Nancy</city>
        <state>Meurthe-et-Moselle</state>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Fuchs-Buder, Prof.</last_name>
      <phone>0033383153942</phone>
      <email>t.fuchs-buder@chu-nancy.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituto Nazionale Dei Tumori</name>
      <address>
        <city>Milano</city>
        <zip>20133</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Franco Valenza, Prof.</last_name>
      <phone>0039 022 390 2282</phone>
      <email>franco.valenza@istitutotumori.mi.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>RadboudUMC</name>
      <address>
        <city>Nijmegen</city>
        <state>Gelderland</state>
        <zip>6525GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michiel C Warlé, PhD</last_name>
      <phone>0031 24 361 5333</phone>
      <email>Michiel.Warle@radboudumc.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>LUMC</name>
      <address>
        <city>Leiden</city>
        <state>Zuid-Holland</state>
        <zip>2333ZA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gijsbert Honing, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Noordwest ziekenhuis groep</name>
      <address>
        <city>Alkmaar</city>
        <zip>1815 JD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Margot Roozekrans, MD</last_name>
      <phone>0031 72 548 4444</phone>
      <email>mhj.roozekrans@nwz.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Netherlands Cancer institute</name>
      <address>
        <city>Amsterdam</city>
        <zip>1066 CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Suzanne Broens, MD</last_name>
      <phone>0031 20 512 9111</phone>
      <email>s.broens@nki.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Canisius Wilhelmina Ziekenhuis</name>
      <address>
        <city>Nijmegen</city>
        <zip>6532 SZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ivo Panhuizen, MD</last_name>
      <phone>0031 24 365 7657</phone>
      <email>ivopan@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari I Politecnic La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Oscar D Cambronero, MD</last_name>
      <phone>0034 656 99 4108</phone>
      <email>oscardiazcambronero@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>https://www.assessurgery.com/</url>
    <description>Link to calculate comprehensive complication index</description>
  </link>
  <reference>
    <citation>Boon M, Martini C, Yang HK, Sen SS, Bevers R, Warlé M, Aarts L, Niesters M, Dahan A. Impact of high- versus low-dose neuromuscular blocking agent administration on unplanned 30-day readmission rates in retroperitoneal laparoscopic surgery. PLoS One. 2018 May 23;13(5):e0197036. doi: 10.1371/journal.pone.0197036. eCollection 2018.</citation>
    <PMID>29791482</PMID>
  </reference>
  <reference>
    <citation>Torensma B, Martini CH, Boon M, Olofsen E, In 't Veld B, Liem RS, Knook MT, Swank DJ, Dahan A. Deep Neuromuscular Block Improves Surgical Conditions during Bariatric Surgery and Reduces Postoperative Pain: A Randomized Double Blind Controlled Trial. PLoS One. 2016 Dec 9;11(12):e0167907. doi: 10.1371/journal.pone.0167907. eCollection 2016.</citation>
    <PMID>27936214</PMID>
  </reference>
  <reference>
    <citation>Martini CH, Boon M, Bevers RF, Aarts LP, Dahan A. Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. Br J Anaesth. 2014 Mar;112(3):498-505. doi: 10.1093/bja/aet377. Epub 2013 Nov 15.</citation>
    <PMID>24240315</PMID>
  </reference>
  <reference>
    <citation>Rosenthal R, Hoffmann H, Clavien PA, Bucher HC, Dell-Kuster S. Definition and Classification of Intraoperative Complications (CLASSIC): Delphi Study and Pilot Evaluation. World J Surg. 2015 Jul;39(7):1663-71. doi: 10.1007/s00268-015-3003-y.</citation>
    <PMID>25665678</PMID>
  </reference>
  <reference>
    <citation>Madsen MV, Scheppan S, Mørk E, Kissmeyer P, Rosenberg J, Gätke MR. Influence of deep neuromuscular block on the surgeonś assessment of surgical conditions during laparotomy: a randomized controlled double blinded trial with rocuronium and sugammadex. Br J Anaesth. 2017 Sep 1;119(3):435-442. doi: 10.1093/bja/aex241.</citation>
    <PMID>28969327</PMID>
  </reference>
  <reference>
    <citation>Özdemir-van Brunschot DMD, Braat AE, van der Jagt MFP, Scheffer GJ, Martini CH, Langenhuijsen JF, Dam RE, Huurman VA, Lam D, d'Ancona FC, Dahan A, Warlé MC. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surg Endosc. 2018 Jan;32(1):245-251. doi: 10.1007/s00464-017-5670-2. Epub 2017 Jun 22.</citation>
    <PMID>28643056</PMID>
  </reference>
  <reference>
    <citation>Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13.</citation>
    <PMID>15273542</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>October 9, 2019</study_first_submitted>
  <study_first_submitted_qc>October 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 11, 2019</study_first_posted>
  <last_update_submitted>February 14, 2020</last_update_submitted>
  <last_update_submitted_qc>February 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Leiden University Medical Center</investigator_affiliation>
    <investigator_full_name>Martijn Boon</investigator_full_name>
    <investigator_title>Prinicipal Investigator</investigator_title>
  </responsible_party>
  <keyword>Laparoscopy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Protocol and SAP will be published before start study. CSR will be reported after article publication in a peer reviewed journal.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Protocol and Statistical Analysis Plan will be published before start study. Clinical Study Report will be reported after article publication in a peer reviewed journal.</ipd_time_frame>
    <ipd_access_criteria>To be declared</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

